載入...
Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors
Despite remarkable responses to cancer immunotherapy in a subset of patients, many patients remain resistant to therapies. It is now clear that elevated levels of tumor-infiltrating T cells as well as a systemic anti-tumor immune response are requirements for successful immunotherapies. However, the...
Na minha lista:
| 發表在: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Gene & Cell Therapy
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7251545/ https://ncbi.nlm.nih.gov/pubmed/32478167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.04.012 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|